146 related articles for article (PubMed ID: 8048153)
1. Validations of time-resolved fluoroimmunoassays for urinary estrone 3-glucuronide and pregnanediol 3-glucuronide.
Kesner JS; Knecht EA; Krieg EF; Barnard G; Mikola HJ; Kohen F; Gani MM; Coley J
Steroids; 1994 Mar; 59(3):205-11. PubMed ID: 8048153
[TBL] [Abstract][Full Text] [Related]
2. Urinary estrone conjugate and pregnanediol 3-glucuronide enzyme immunoassays for population research.
O'Connor KA; Brindle E; Holman DJ; Klein NA; Soules MR; Campbell KL; Kohen F; Munro CJ; Shofer JB; Lasley BL; Wood JW
Clin Chem; 2003 Jul; 49(7):1139-48. PubMed ID: 12816911
[TBL] [Abstract][Full Text] [Related]
3. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
Stanczyk FZ; Miyakawa I; Goebelsmann U
Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility and validity of radioimmunoassays for urinary hormones and metabolites in pre- and postmenopausal women.
Falk RT; Gail MH; Fears TR; Rossi SC; Stanczyk F; Adlercreutz H; Kiura P; Wahala K; Donaldson JL; Vaught JB; Fillmore CM; Hoover RN; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):567-77. PubMed ID: 10385149
[TBL] [Abstract][Full Text] [Related]
5. Multiple immunoassay: the simultaneous measurement of two urinary steroid glucuronides as an index of ovarian function.
Weerasekera DA; Kim JB; Barnard GJ; Collins WP
J Steroid Biochem; 1983 Apr; 18(4):465-70. PubMed ID: 6300555
[TBL] [Abstract][Full Text] [Related]
6. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
[TBL] [Abstract][Full Text] [Related]
7. Direct assay of urinary steroid glucuronides for monitoring the approach of ovulation.
Merlo AB; Farinati Z; Quiroga S; Nagle CA; Carril LM; Lahoz M; Mendizabal AF
Int J Fertil; 1984; 29(3):189-93. PubMed ID: 6152260
[TBL] [Abstract][Full Text] [Related]
8. Specificity studies of monoclonal and rabbit antibodies raised against steroid glucuronides.
Samarajeewa P; Weerasekera DA; Coulson WF
Steroids; 1981 Dec; 38(6):667-78. PubMed ID: 6175056
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of using paper impregnated with urine instead of liquid urine for assessing ovarian activity.
Wasalathanthri S; Tennekoon KH; Sufi S
Ceylon Med J; 2003 Mar; 48(1):4-6. PubMed ID: 12795010
[TBL] [Abstract][Full Text] [Related]
10. Mean versus individual hormonal profiles in the menstrual cycle.
Alliende ME
Fertil Steril; 2002 Jul; 78(1):90-5. PubMed ID: 12095496
[TBL] [Abstract][Full Text] [Related]
11. Monitoring ovarian function by the simultaneous time-resolved fluorescence immunoassay of two urinary steroid metabolites.
Barnard G; Kohen F
Clin Chem; 1998 Jul; 44(7):1520-8. PubMed ID: 9665432
[TBL] [Abstract][Full Text] [Related]
12. Use of a monoclonal antibody to estrone-3-glucuronide in an enzyme-linked immunosorbent assay (ELISA).
Elder PA; Manley L; Lewis JG
J Steroid Biochem; 1990 Aug; 36(5):439-43. PubMed ID: 2170764
[TBL] [Abstract][Full Text] [Related]
13. Pattern of excretion of urinary steroid metabolites during the ovarian cycle and pregnancy in the marmoset monkey.
Eastman SA; Makawiti DW; Collins WP; Hodges JK
J Endocrinol; 1984 Jul; 102(1):19-26. PubMed ID: 6330265
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
16. Measurement of glucuronometabolites of 17 beta-estradiol and progesterone in diluted overnight urine. An approach to the study of luteal insufficiency.
Pazzagli M; Magini A; Forti G; Bolelli G; Scarselli G; Noci I; Pellegrini S; Rodbard D; Serio M
J Steroid Biochem; 1987; 27(1-3):399-404. PubMed ID: 3695488
[TBL] [Abstract][Full Text] [Related]
17. The OVEIA Dual Analyte assay--a new method for profiling the menstrual cycle.
Baker TS
Prog Clin Biol Res; 1988; 285():101-18. PubMed ID: 3231642
[TBL] [Abstract][Full Text] [Related]
18. Chemical and homogeneous enzyme immunoassay methods for the measurement of estrogens and pregnanediol and their glucuronides in urine.
Brown JB; Blackwell LF; Cox RI; Holmes JM; Smith MA
Prog Clin Biol Res; 1988; 285():119-38. PubMed ID: 3068673
[No Abstract] [Full Text] [Related]
19. Urinary excretion of estrone glucosiduronate, 17 beta-estradiol-17-glucosiduronate, and estriol-16 alpha-glucosiduronate. Significance of proportionate differences during the menstrual cycle.
Wright K; Collins DC; Preedy JR
Steroids; 1979 Oct; 34(4):445-57. PubMed ID: 229588
[TBL] [Abstract][Full Text] [Related]
20. Ovarian function in premenopausal women affected by breast cancer: the measurement of glucuronoconjugate metabolites of 17 beta-estradiol and progesterone throughout one entire menstrual cycle.
Magini A; Pazzagli M; Salerno R; Simonis M; Mustacchi G; Serio M
J Steroid Biochem; 1990 Aug; 36(6):523-6. PubMed ID: 2214768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
